Litcius/Paper detail

Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells

Karim I. Mersal, Mohammed S. Abdel‐Maksoud, Eslam M.H. Ali, Usama M. Ammar, Seyed–Omar Zaraei, Md. Mamunul Haque, Tanuza Das, Noha F. Hassan, Eunice EunKyeong Kim, Jun‐Seok Lee, HaJeung Park, Kwan H. Lee, Mohammed I. El–Gamal, Hee-Kwon Kim, Tamer M. Ibrahim, Chang‐Hyun Oh, Chang‐Hyun Oh

2023European Journal of Medicinal Chemistry14 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryKinaseIC50PotencyCytotoxicityCell cultureK562 cellsApoptosisStereochemistryMolecular biologyBiochemistryIn vitroBiologyGeneticsMelanoma and MAPK PathwaysQuinazolinone synthesis and applicationsCancer therapeutics and mechanisms
Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells | Litcius